Categories Multiple Myeloma

William R. MSgt. USAF TOPOR

William R. MSgt. USAF TOPOR TOPOR, William R., MSgt. USAF (Age 82) “I will meet you when my chores are done” Love, me. by Collin Raye After fighting a valiant four year battle with Multiple Myeloma, along with the loss of his beloved wife, Carole, Bill passed away peacefully at Holy Family Hospital on November […]

Read More
Categories Multiple Myeloma

Immunotherapy for treating multiple myeloma

Immunotherapy for treating multiple myeloma Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, discusses immunotherapeutic interventions to treat multiple myeloma. Dr Raje highlights allogeneic CAR T-cells that are currently in clinical trials. Belantamab mafodotin, an immunoconjugate targeting B-cell maturation antigen (BCMA), as used in the DREAMM trials (NCT04126200/NCT03525678), is now approved by the FDA and […]

Read More
Categories Parkinson's Disease

The World of Eiro Research

”; Network marketing is certainly not a new concept as it has been around for decades. However, many may be discovering network marketing for the first time due to the incredible rise in popularity of the process. Why has network marketing become so popular in recent years? The rise of the internet as a promotional […]

Read More
Categories Cancer

Clinicopathological and Prognostic Significance of PRAME Overexpression in Human Cancer: A …

Clinicopathological and Prognostic Significance of PRAME Overexpression in Human Cancer: A … Numerous studies have demonstrated that preferentially expressed antigen in melanoma (PRAME) is abnormally expressed in various solid tumours. However, the clinicopathological features and prognostic value of the PRAME expression in patients with cancer remain unclear. Accordingly, we performed a meta-analysis to accurately assess […]

Read More
Categories Multiple Myeloma

Clinical management of plasma cell leukemia: an update

Clinical management of plasma cell leukemia: an update Francesca Gay, MD, PhD, of the University of Turin, Turin, Italy, briefly describes the major differences in the clinical presentation of plasma cell leukemia (PCL) and multiple myeloma (MM), including age, severity and risk of chromosomal abnormalities, despite both being plasma cell neoplasms. Dr Gay goes on […]

Read More
Categories Cancer

Adding checkpoint inhibitor to chemotherapy improves responses without negatively impacting …

Adding checkpoint inhibitor to chemotherapy improves responses without negatively impacting … Adding an immune checkpoint inhibitor to the standard chemotherapy regimen for patients with early-stage breast cancer places no greater burden on patients’ ability to perform day-to-day activities than chemotherapy alone, new research by Dana-Farber/Brigham and Women’s Cancer Center investigators shows. The report, coupled with […]

Read More
Categories Cancer

Metastatic Cancer Treatment Market Size To Be Worth USD 111.16 Billion by 2027 | Emergen …

Metastatic Cancer Treatment Market Size To Be Worth USD 111.16 Billion by 2027 | Emergen … Vancouver, British Columbia, Dec. 10, 2020 (GLOBE NEWSWIRE) — The Global Metastatic Cancer Treatment Market is projected to be worth USD 111.16 Billion by 2027, according to the current analysis by Emergen Research. The market is anticipated to witness […]

Read More